Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores

Launched by DHURAKIJ PUNDIT UNIVERSITY · Feb 28, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment for people with enlarged facial pores. Researchers want to see if a special microneedle patch that contains botulinum toxin (the same substance used in Botox) can help improve the appearance of these pores. The trial is currently active but not recruiting new participants.

To be eligible for this study, you need to be at least 18 years old and concerned about your enlarged pores, specifically if they measure between 0.3 and 0.6 mm in size. Participants will not be accepted if they have certain medical conditions, are pregnant or breastfeeding, or have had specific treatments or medications in the past few months that could interfere with the study. If you join, you can expect to use the microneedle patch and be monitored for its effectiveness and safety. This trial offers a chance to explore a new approach to managing enlarged pores, which can be a common cosmetic concern for many people.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • At least 18 years old and concerned about enlarged pores
• • Have pore size 0.3-0.6 mm
• • Have pore parameter in each other side of faces not different more than 5%
• Exclusion Criteria:
• • Any neuromuscular condition
• • Pregnancy or breast feeding
• • History of allergy : Botulinum toxin, topical anesthesia
• • History of keloid or hypertrophic scar
• • History of coagulation or receiving medication that causes coagulation disorder
• • Using drugs that have interaction with Botulinum toxin
• • Using topical medication that improves enlarged pores in 1 month
• • Taking medication that improves enlarged pores in 1 month
• • Receiving the laser/treatment/chemical peeling in 6 months